SciDev.Net

Poor countries need support to participate in genomics research, say Josefina Coloma and Eva Harris in PLoS Medicine.

Interrupting funding for mass treatment of lymphatic filariasis can lead to a quick resurgence in the disease, say Kimberly Won and colleagues.

A lack of political will to create vaccines is causing millions of deaths a year due to infectious diseases, says Manuel Elkin Patarroyo.

The biotech industry has advantages over pharma for drug discovery for neglected diseases, say Joanna E. Lowell and Christopher D. Earl.

GlaxoSmithKline plans to cut medicine prices and create a 'patent pool' — but does any of this reflect a real drive to boost the health of the poor?

While progress has been made in tackling lymphatic filariasis, we are still long way from eliminating the disease, says David H. Molyneux.

Eliminating schistosomiasis means using strategies that combine drug delivery, water management and snail control, says Charles H. King.

Understanding how neglected tropical diseases affect chronic diseases can help inform health policies, say Peter Hotez and Abdallah Daar.

FDA priority review vouchers will not necessarily encourage research into tropical diseases, argues Aaron Kesselheim.

Malaria control efforts should be joined with those of neglected tropical diseases to achieve eradication, say Peter J. Hotez and David H. Molyneux.

Public-private partnership organisations have failed to include African researchers on an equal basis, say T. J. Tucker and M. W. Makgoba.

Elimination of blinding trachoma is entirely possible by 2020, says the New England Journal of Medicine.

Peter J. Hotez believes the establishment of a new financing mechanism is vital for the control and eradication of neglected diseases.

Amy C. Morrison and colleagues outline key preventative measures for controlling the Aedes aegypti mosquito that spreads disease.

Greg W. Fegan and Trudie A. Lang urge the use of open-source database systems to increase the scope and variety of clinical trials.

Peter J. Hotez argues that the Guantanamo camp should be converted into a research institute for Latin America's neglected diseases.

Brazil should use its resources to form a public–private partnership to tackle its neglected disease burden, says Peter J. Hotez.